As of August 2026, 13 paid clinical trials are recruiting for Psychiatry in Everett, Washington. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Everett, WA at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Regional Cancer Partnership | Malignant Solid Neoplasm, Breast Cancer, Ovarian Carcinoma | 35 |
| Core Clinical Research | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 17 |
| Providence Regional Medical Center Everett | COVID-19, Central Line Associated Blood Stream Infections (CLABSI), Clostridoides Difficile Associated Disease | 6 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| Alkermes Investigational Site | Bipolar I Disorder, Schizophrenia | 1 |
| Alkermes Investigator Site | Bipolar I Disorder, Schizophrenia | 1 |
| Cornerstone P&O | Lower Extremity, Pareses | 1 |
| Cornerstone Prosthetics and Orthotics | Lower Extremity Injuries | 1 |
| Local Institution - 0003 | Major Depressive Disorder | 1 |
| Local Institution - 0019 | Irritability Associated With Autism Spectrum Disorder | 1 |
| Local Institution - 0155 | Autism-Related Irritability, Schizophrenia | 1 |
| Providence Everett | Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III | 1 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 1 |
| Vanda Investigational Site | Bipolar I Disorder, Schizophrenia | 1 |
| Western Washington Medical Group | Cardiovascular Disease | 1 |
Recruiting trials in Everett grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 72 recruiting clinical trials in Everett, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Everett compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Everett include Bipolar I Disorder (7), Major Depressive Disorder (7), Schizophrenia (5), Bipolar Depression (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Everett on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Everett include Providence Regional Cancer Partnership, Core Clinical Research, Providence Regional Medical Center Everett, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Everett are Cancer & tumors (24), Mental health & behavior (13), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.